The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study

BACKGROUND: World Health Organization (WHO) has recommended individuals with increased risk of contracting influenza A H5N1 infection to be immunized against the virus during the inter-pandemic period. Safety and immunogenicity of H5N1 vaccine among participants primed with homologous or heterologou...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Infect Dis
Auteurs principaux: Wei, Sung-Hsi, Liu, Ming-Tsan, Tsai, Yao-Chou, Liao, Chung-Hsin, Chen, Chih-Ming, Wang, Wei-Yao, Huang, Yi-Lung, Chang, Feng-Yee, Chou, Pesus
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4236496/
https://ncbi.nlm.nih.gov/pubmed/25394941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-014-0587-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires